MX388654B - Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón. - Google Patents

Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón.

Info

Publication number
MX388654B
MX388654B MX2017014912A MX2017014912A MX388654B MX 388654 B MX388654 B MX 388654B MX 2017014912 A MX2017014912 A MX 2017014912A MX 2017014912 A MX2017014912 A MX 2017014912A MX 388654 B MX388654 B MX 388654B
Authority
MX
Mexico
Prior art keywords
treatment
damage
kidney
prophylaxis
organ damage
Prior art date
Application number
MX2017014912A
Other languages
English (en)
Other versions
MX2017014912A (es
Inventor
Der Graaf Adrianus Cornelis Van
Gerrit Jan Willem Euverink
Leo Edwin Deelman
Robert Henk Henning
Original Assignee
Sulfateq Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56014996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX388654(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sulfateq Bv filed Critical Sulfateq Bv
Publication of MX2017014912A publication Critical patent/MX2017014912A/es
Publication of MX388654B publication Critical patent/MX388654B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos para la profilaxis o el tratamiento del daño al órgano mediante la restauración de la función endotelial y/o la inhibición de la producción de especies de oxígeno reactivas y especialmente a compuestos para la profilaxis o el tratamiento del daño renal diabético. Específicamente, la invención presente relaciona a 6-hidroxi-2,5,7,8-tetrametilcroman-2-il) (piperazin-1-il)metanona o N, 6-dihidroxi-2,5,7,8-tetrametilcroman-2-carboxamida o una sal o base farmacéuticamente aceptable de los mismos para el uso en la profilaxis o tratamiento del daño al órgano mediante la restauración de la función endotelial o la inhibición de la producción de especies reactivas de oxígeno y daño órgánico a los riñones diabéticos.
MX2017014912A 2015-05-22 2016-05-12 Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón. MX388654B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2014843 2015-05-22
PCT/EP2016/060731 WO2016188766A1 (en) 2015-05-22 2016-05-12 Compound for the prophylaxis or treatment of organ damage

Publications (2)

Publication Number Publication Date
MX2017014912A MX2017014912A (es) 2018-06-13
MX388654B true MX388654B (es) 2025-03-20

Family

ID=56014996

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014912A MX388654B (es) 2015-05-22 2016-05-12 Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón.

Country Status (15)

Country Link
US (2) US10676452B2 (es)
EP (1) EP3297625B1 (es)
JP (2) JP6967456B2 (es)
CN (1) CN107660148B (es)
AU (1) AU2016268975B2 (es)
BR (1) BR112017024854B1 (es)
CA (1) CA2986300C (es)
CL (1) CL2017002960A1 (es)
DK (1) DK3297625T3 (es)
ES (1) ES2927699T3 (es)
HU (1) HUE060167T2 (es)
MX (1) MX388654B (es)
PL (1) PL3297625T3 (es)
PT (1) PT3297625T (es)
WO (1) WO2016188766A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2010010C2 (en) * 2012-12-19 2014-06-23 Sulfateq B V Compounds for protection of cells.
MX388654B (es) * 2015-05-22 2025-03-20 Sulfateq Bv Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón.
US12156862B2 (en) 2017-08-25 2024-12-03 Sulfateq B.V. Medicaments for the treatment of vasoconstriction related diseases or disorders
US11730741B2 (en) 2017-08-25 2023-08-22 Sulfateq B.V. 6-chromanol derivatives for use as a medicament
MX2020005238A (es) 2017-11-22 2020-08-24 Khondrion Ip B V Compuestos novedosos como inhibidores mpges-1.
NL2025730B1 (en) * 2020-06-02 2022-01-20 Sulfateq Bv Compounds for treatment of sepsis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681890A (en) 1984-10-30 1987-07-21 Kuraray Co., Ltd. 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
US4728650A (en) 1985-05-13 1988-03-01 Kuraray Co., Ltd. 3,4-dihydrobenzopyran derivatives and medicinal uses thereof
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
US5266709A (en) 1989-03-13 1993-11-30 Ono Pharmaceutical Co., Ltd. Benzopyran derivatives
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
FR2756284B1 (fr) 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6335445B1 (en) * 1997-03-24 2002-01-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
WO1997041121A1 (en) 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
AR019190A1 (es) * 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2003221281A1 (en) 2003-02-26 2004-09-17 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Benzopyran compounds, process for preparing the same and their use
EP1650206A4 (en) * 2003-08-01 2006-12-20 Nippon Soda Co PHENYLAZOLE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND ANTIOXIDANTS
WO2005032544A1 (en) * 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Treatment of mitochondrial diseases
RS55813B2 (sr) * 2012-07-12 2019-12-31 Khondrion Ip B V Hromanil derivati za tretiranje mitohondrijalne bolesti
NL2010010C2 (en) 2012-12-19 2014-06-23 Sulfateq B V Compounds for protection of cells.
MX388654B (es) * 2015-05-22 2025-03-20 Sulfateq Bv Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón.

Also Published As

Publication number Publication date
HUE060167T2 (hu) 2023-02-28
US10676452B2 (en) 2020-06-09
US20180170892A1 (en) 2018-06-21
EP3297625A1 (en) 2018-03-28
JP6967456B2 (ja) 2021-11-17
CN107660148B (zh) 2021-03-09
BR112017024854A2 (pt) 2018-08-14
EP3297625B1 (en) 2022-07-06
CL2017002960A1 (es) 2018-03-16
DK3297625T3 (da) 2022-10-17
ES2927699T3 (es) 2022-11-10
CA2986300A1 (en) 2016-12-01
WO2016188766A1 (en) 2016-12-01
PL3297625T3 (pl) 2022-11-14
PT3297625T (pt) 2022-09-27
JP2018520106A (ja) 2018-07-26
CA2986300C (en) 2024-02-20
MX2017014912A (es) 2018-06-13
AU2016268975A1 (en) 2017-11-30
AU2016268975B2 (en) 2021-08-12
JP2021120381A (ja) 2021-08-19
CN107660148A (zh) 2018-02-02
US20210024485A1 (en) 2021-01-28
BR112017024854B1 (pt) 2023-12-26

Similar Documents

Publication Publication Date Title
SA520411125B1 (ar) Nlrp مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط
CL2020000886A1 (es) Derivados de 1-benzil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de la proteasa del vih.
MX388654B (es) Derivados de cromano y uso de los mismos en el tratamiento de daño en un órgano diabético, tal como un riñón.
CO2018009275A2 (es) Derivados pirrolidina espiro-condensados como inhibidores de enzimas desubiquitinantes (dub)
EA201691194A1 (ru) Стимуляторы ргц
MD4820B1 (ro) Compuşi dihidroizochinolinonici substituiţi
UY35972A (es) Inhibidores macrocíclicos de fxia que tienen grupos heterocíclicos
PH12016501963A1 (en) Macrocyclic pyrimidine derivatives
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
MX2014005342A (es) Inhibidores del virus de la hepatitis c.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
MX2016010451A (es) Benzoxaboroles microbicidamente activos.
CL2016002422A1 (es) Cromeno y 1, 1a,2,7b-tetrahidrociclopropa[c]cromeno piridopirazinadionas como moduladores de gamma-secretasas.
MX2018004664A (es) Antagonistas de ep4.
MX2017013137A (es) Derivados de cromeno como inhibidores de las fosfoinositido-3-cina sas.
CR20180091A (es) 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del vih
ECSP16083017A (es) Derivados de diheterociclo enlazado a cicloalquilo
EA201791396A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
MX2017008076A (es) DERIVADOS DE IMIDAZOPIRIDAZINA ENLAZADOS A HETEROCICLILO COMO INHIBIDORES DE PI3Kß.
TR201813294T4 (tr) N-aril-2-amino-4-aril-pirimidin makrosi̇kli̇k poli̇eter türevleri̇ ve bunlarin flt3 ve jak i̇nhi̇bi̇törleri̇ olarak kullanimlari.
MX2017002544A (es) Derivados de isoquinolinona utiles en el tratamiento contra el cancer.
CL2018002347A1 (es) Nuevos derivados pirrolidina
MX2017002747A (es) Derivados de polieteres macrociclicos de n-aril-triciclopirimidin- 2-amino como inhibidores de ftl3 y jak.
PL405507A1 (pl) Pochodne S-metyloestru kwasu 7-karboksybenzo[1,2,3]tiadiazolowego
DOP2016000326A (es) Compuestos de dihidroisoquinolinona sustituida